Anti-cMet antibody drug conjugates and methods for their use
US10383948B2 · kind B2 · utility
4Cited by
12References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 2, 2018 |
| Grant date | Aug 20, 2019 |
| Priority date | — |
| Expiry date | Mar 2, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides antibody drug conjugates that bind human cMET, their methods of making, and their uses to treat patients having cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.